Papers matching “LDL cholesterol lowering” 181
Not finding it? Sign in to also search OpenAlex live.
-
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial2020 European Heart Journal article Medicine Lipoproteins and Cardiovascular Health Open access cited by 2 patents
Michael J. Szarek, Vera Bittner, Philip E. Aylward, Marie T. Baccara‐Dinet, Deepak L. Bhatt, Rafael Díaz, +16 more
221citations -
Cardiovascular event rate modifies response to pharmacologic LDL-C lowering in primary prevention: implications of a systematic review and meta-analysis for clinical practice2026 American Journal of Preventive Cardiology review Medicine Lipoproteins and Cardiovascular Health Open access
Irene Karungi, Christophe A. T. Stevens, Julia Brandts, Kausik Kumar Ray
4citations -
Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway project2020 Atherosclerosis Supplements article Medicine Lipoproteins and Cardiovascular Health Open access
Ulf Landmesser, Angela Pirillo, Michel Farnier, J. Wouter Jukema, Ulrich Laufs, François Mach, +8 more
38citations -
Quality control to improve LDL-cholesterol management in patients with acute coronary syndromes based on the ACS EuroPath IV project2023 European Heart Journal Acute Cardiovascular Care article Medicine Lipoproteins and Cardiovascular Health Open access
François Schiele, Alberico Luigi Catapano, Raffaele De Caterina, Ulrich Laufs, J. Wouter Jukema, Azfar Zaman, +1 more
7citations -
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol2021 Journal of the American College of Cardiology article Medicine Lipoproteins and Cardiovascular Health Open access
Gregory G. Schwartz, Vera A. Bittner, Patricio López‐Jaramillo, Garen Z. Manvelian, Robert C. Pordy, Michel Scemama, +61 more
147citations -
Effects of Lipidrive®/TOTUM-070, a polyphenol-rich compound, on LDL-cholesterol in subjects with moderate hypercholesterolemia (the HEART study): A randomized, double-blind, placebo-controlled trial2025 Archives of cardiovascular diseases article Medicine Natural Products and Biological Research Open access
Arnaud Michaux, Y.F. Otero, Marie Vallier, Maxime Bargetto, Florian Le Joubioux, Thierry Maugard, +3 more
0citations -
Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial
Gregory G. Schwartz, Michael J. Szarek, Deepak L. Bhatt, Vera Bittner, Maja Bujas‐Bobanovic, Rafael Díaz, +11 more
47citations -
Schistosoma haematobium infection is associated with lower serum cholesterol levels and improved lipid profile in overweight/obese individuals2020 PLoS neglected tropical diseases article Immunology and Microbiology Parasites and Host Interactions Open access
Jeannot Fréjus Zinsou, Jacqueline J. Janse, Yabo Josiane Honkpéhèdji, Jean Claude Dejon Agobe, Noemí García‐Tardón, Pytsje T. Hoekstra, +8 more
32citations -
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI2022 Cardiovascular Drugs and Therapy article Medicine Lipoproteins and Cardiovascular Health Open access
Antonio J. Vallejo‐Vaz, Sarah L Bray, Guillermo Villa, Julia Brandts, Gaia Kiru, Maciej Banach, +23 more
18citations -
L ow‐density lipoprotein cholesterol and non‐high‐density lipoprotein cholesterol in type 1 diabetes and type 2 diabetes: Lipid goal attainment in a large German–Austrian diabetes registry2023 Diabetes Obesity and Metabolism article Medicine Lipoproteins and Cardiovascular Health Open access
Julia Brandts, Sascha René Tittel, Peter Bramlage, Thomas Danne, Johanna Maria Brix, Stefan Zimny, +3 more
30citations -
Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab2020 European Journal of Preventive Cardiology article Medicine Lipoproteins and Cardiovascular Health Open access
Antonio J. Vallejo‐Vaz, Lawrence A. Leiter, Stefano Del Prato, Marja‐Riitta Taskinen, Dirk Müller‐Wieland, Maja Bujas‐Bobanovic, +4 more
15citations